Two office buildings in Collegeville have sold to Audubon-based Globus Medical for $6.2 million, marking an 81 percent drop ...

BTIG analysts have downgraded Globus Medical from "Buy" to "Neutral" amid fears surrounding the company's Spine business.

Zimmer Biomet announced today that it appointed Kevin Thornal as group president, global businesses and the Americas.

Thornal will join the orthopedics company as group president for global businesses and the Americas, a newly created position.

Zimmer Biomet named Kevin Thornal as group president for global business and the Americas, according to a May 27 news release. Mr. Thornal will join the company July 1. He was previously CEO and ...

Globus Medical seems to be reverting to form, reporting a big jump in operating profit and profit margin for Q1, 2025. Here ...

Nevro employs HFX spinal cord stimulation, which is used in its Senza SCS system. The company also offers minimally invasive treatments for chronic sacroiliac joint pain. 4. Globus Medical CEO Daniel ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Globus Medical, Inc. is a leading global musculoskeletal company ... the risks and costs associated with the integration of the NuVasive and Nevro businesses and our ability to successfully integrate ...

Barclays raised their target price on shares of Globus Medical from $100.00 to $103.00 and gave the stock an “overweight” rating in a research note on Monday, February 24th. Needham & Company ...

About Globus Medical, Inc. Globus Medical ... the risks and costs associated with the integration of the NuVasive and Nevro businesses and our ability to successfully integrate and achieve anticipated ...